Specialists at Abramson Cancer Center utilize modern tools to evaluate and develop individualized treatment plans for non-Hodgkin lymphoma.
Non-Hodgkin lymphomas are cancers of lymphocytes, which are white blood cells that circulate throughout the blood and bone marrow. These cancers are called "non-Hodgkin" because they have a different appearance from that of Hodgkin lymphomas.
Non-Hodgkin lymphoma may be difficult to diagnose and it’s very important to get an accurate subtype diagnosis.
Penn Medicine is a leader in treating non-Hodgkin lymphoma and develops personalized treatment plans for each individual.